Table 4.
Associations between guideline adherence and ESKD risk using time-dependent Cox models
ADA guideline | Chinese guideline | |||
Adjusted HR (95% CI) | P value | Adjusted HR (95% CI) | P value | |
Antihyperglycemic therapy | 0.71 (0.55 to 0.9) | 0.006 | 0.74 (0.58 to 0.95) | 0.016 |
Hypertension control | 0.89 (0.66 to 1.21) | 0.471 | 0.66 (0.50 to 0.87) | 0.004 |
Lipid management | 0.95 (0.76 to 1.19) | 0.658 | 0.52 (0.39 to 0.71) | <0.001 |
Adjusted HR and p value were obtained via time-dependent Cox models to adjust for sex, age, eGFR, duration of diabetes and time-dependent covariates (HbA1c, systolic BP, diastolic BP, LDL-C, TG, PRO, UA).
ADA, American Diabetes Association; BP, blood pressure; eGFR, estimated glomerular filtration rate; ESKD, end-stage kidney disease; HbA1c, hemoglobin A1c; LDL-C, low-density lipoprotein cholesterol; PRO, proteinuria; TG, triglyceride; UA, uric acid.